Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The aim of the study is to show that first line treatment with concentrated fibrinogen has
superiority over the conventional therapy with fresh frozen plasma (FFP), platelets, and
cryoprecipitate in perioperative management of bleeding after complex cardiac surgery.